...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Two things with the name confusion:

 

1. When they ran the NAUNS (name search), how were these two enties allowed to have the same name, one with Corp. and one with Corporation?

2. Why dont we change our name to avoid this issue in the near term and any future issue if we ever make it to a stock exchange

Sometimes you just shake your head

 

Share
New Message
Please login to post a reply